Basal cell carcinoma (BCQ), an essentially indolent, locally destructive epidermal malignancy, is the commonest tumour affecting white populations The overall worldwide incidence of BCC is increasing by approximately 10% per annum, so its prevalence will soon equal that of all other cancers combined Ultraviolet radiation is regarded as critical in the pathogenesis of BCC but the relationship remains obscure Immunosuppressive therapy in renal transplant recipients increases tenfold the risk of developing BCC There are several clinical and histological variants of BCC of which the morphoeic variant is the most aggressive.
CITATION STYLE
Brocke, R. C. C. (2005). Basal cell carcinoma. Clinical Medicine, Journal of the Royal College of Physicians of London. Royal College of Physicians. https://doi.org/10.7861/clinmedicine.5-6-551
Mendeley helps you to discover research relevant for your work.